15 Hrs
Source:
وكالة الانباء العراقية (واع)
Russia registers drug for aggressive cancer
The Russian Ministry of Health announced the approval of a new drug called “Elefuza” for the treatment of advanced cases of breast and ovarian cancer in patients with genetic mutations in BRCA1 and BRCA2. The drug aims to provide a targeted treatment option for patients suffering from severe forms of the disease who are resistant to other therapies.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)